Pediatric and Geriatric Article Archive CD from the International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

PEDIATRICS AND GERIATRICS

Online access to Journal articles and formulations within one or more related compounding topics.

Full-color, full-text PDF files of articles and formulations from the Journal.
Print or save articles for your research, marketing, and educational needs.
Log-in to your account for keyword or topical search and download.
Purchased items appear with download icon in contents and search results.

Only $20000

(Select Format)

This archive contains the following articles listed by volume, issue and page number:

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
PEDIATRICS RELATED ARTICLES
Physicochemical Stability of the Extemporaneous Ibuprofen Oral Suspension in "Wagner" Base Spennacchio Antonio, Lopedota Angela, la Forgia Flavia, Fontana Sergio, Franco Massimo, Denora Nunzio	Jan/Feb 2023 Pg. 72-77
Compounding for Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases Harrington Amy, Williams LaVonn	Jul/Aug 2022 Pg. 293-296
Azstarys in Ora-Blend Single Dose Allen Loyd V Jr	May/Jun 2022 Pg. 233
Enalapril Maleate 1 mg-mL in Ora-Plus and Ora-Sweet Suspension Allen Loyd V Jr	Jan/Feb 2022 Pg. 56
Quetiapine Fumarate 10 mg/mL in Ora-Blend Allen Loyd V Jr	Nov/Dec 2021 Pg. 506
Ziprasidone Mesylate 2.5 mg/mL in Ora-Sweet Suspension Allen Loyd V Jr	Nov/Dec 2021 Pg. 509
Calculations Stockton Shelly J	Jul/Aug 2021 Pg. 318
Atomoxetine 4-mg/mL Oral Solution/Suspension Allen Loyd V Jr	Jul/Aug 2021 Pg. 321
Study on the Optimal Conditions for Long-term Storage of Melatonin Powder as an In-hospital Preparation Odanaka Keita, Kojima Hiroki, Nakagawa Naoto	May/Jun 2021 Pg. 258-262
Amlodipine 1-mg/mL in Oral Mix Suspension Allen Loyd V Jr	Mar/Apr 2021 Pg. 142
Eslicarbazepine Acetate 40-mg/mL in Ora-Plus with Ora-Sweet or Ora-Sweet SF Suspension Allen Loyd V Jr	Mar/Apr 2021 Pg. 144
Calculations Stockton Shelly J	Jan/Feb 2021 Pg. 40
Always the Right Dose? Content Uniformity in Over 100 Different Formulations Tested Dijkers Eli, Polonini Hudson, de Oliveira Ferreira Anderson	Sep/Oct 2020 Pg. 408-412
Sorafenib Capsules for Pediatric Use Allen Loyd V Jr	Sep/Oct 2019 Pg. 411
Extemporaneous Indomethacin Oral Suspension Prepared from Injectable Ampules for Therapy in Premature Infants and Pediatric Patients de Lafuente Yanina, García Mónica Cristina, Jiminez-Kairuz Alvaro	Jul/Aug 2019 Pg. 324-331
Methotrexate 2-mg/mL Oral Solution Allen Loyd V Jr	May/Jun 2019 Pg. 235
Basics of Compounding: Standardization of Compounded Medications Allen Loyd V Jr	Jan/Feb 2019 Pg. 35-44
PreScription: Standardized Concentrations: Pro or Con? Allen Loyd V Jr	Nov/Dec 2018 Pg. 444
Current Trends and Emerging Priorities in Compounded Preparations for Children Parrish Richard H II	Sep/Oct 2018 Pg. 358-366
Stability of Dalteparin 1,000 Unit/mL in 0.9% Sodium Chloride for Injection in Polypropylene Syringes Kirkham Kylian, Munson Jessica M, McCluskey Susan V, Graner Kevin K	Sep/Oct 2017 Pg. 426-429
Simple Preparation of Timolol 0.5% Gel from Eye Drop Solution for Superficial Infantile Hemangiomas Choo Winnie	Jul/Aug 2017 Pg. 282-289
Suspensions as a Valuable Alternative to Extemporaneously Compounded Capsules Dijkers Eli, Nanhekhan Valerie, Thorissen Astrid, Polonini Hudson	Mar/Apr 2017 Pg. 171-175
Case Report: Pediatric Scar Management After Open-heart Surgery Phan Ha, Harger Beau, Estrada Nick	Jul/Aug 2016 Pg. 277-280
Extended Stability of Morphine and Sildenafil for Oral Use in Infants and Young Children Nahata Milap C	May/Jun 2016 Pg. 247-249
Development of Extemporaneously Compounded Aripiprazole Oral Suspensions for Use in Children Pramann Lance A, Davidow Lawrence W, van Haandel Leon, Funk Ryan S	May/Jun 2016 Pg. 257-261
Extemporaneous Compounding of Oral Acitretin Suspension for Pediatric Patient with Generalized Pustular Psoriasis Choo Winnie	Jan/Feb 2016 Pg. 6-10
Practicing Your Compounding Skills Outsides of Your Pharmacy's Walls Gonzalez Mark	May/Jun 2015 Pg. 205-211
L-Cysteine Hydrochloride 50-mg/mL Injection Allen Loyd V Jr	Mar/Apr 2015 Pg. 146
Physicochemical and Microbiological Stabilities of Hydrocortisone in InOrpha Suspending Agent Studied Under Various Condition Bourget Philippe, Amin Alexandre, Vidal Fabrice, Pieyre Manon, Dosso El Ourmar, Beauvais Raphaelle, Loeuillet Richard	Sep/Oct 2014 Pg. 427-431
The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013 Lutz Eugene, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc	Jan/Feb 2014 Pg. 6-12
Disguising the Taste of Antiretrovirals for Pediatric Patients Infected with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: Creative Flavor Compounding and Techniques, Part 2 Horace Alexis E, Akbarian-Tefagh Jessica	Nov/Dec 2013 Pg. 446-450
Preventing Medication Errors with Nimodipine by Compounding Proper Dosage Forms McElhiney Linda F	Sep/Oct 2013 Pg. 364-368
Disguising the Taste of Antiretrovirals for Pediatric Patients Infected with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: Creative Flavor Compounding and Techniques, Part 1 Horace Alexis E, Akbarian-Tefagh Jessica	Sep/Oct 2013 Pg. 388-391
Indomethacin 1-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2013 Pg. 419
Pattern of Extemporaneous Prescriptions and Preparations in a Tertiary Health Institution: A Five-year Assessment Aghahowa S E, Egharevba J O, Erhagbe B E, Okoh F	Sep/Oct 2013 Pg. 432-435
Pediatric Health Care: An Introduction Williams LaVonn A	Jan/Feb 2013 Pg. 6-8
A Concise Discussion of Headache Types, Part 3: Migraine Williams LaVonn A, Allen Loyd V Jr	Jul/Aug 2012 Pg. 270-274
A Retrospective Observational Case Series Analysis of the Usage of Hydroxyprogesterone Caproate for the Prevention of Preterm Labor in Alabama Patients Nolan Sara M, Burgess Christopher A	Nov/Dec 2011 Pg. 446-448
Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers Zur Eyal	Nov/Dec 2011 Pg. 458-463
Diaper Rash Relief: Common Sense Remedies and Treatments Wiliams Kacee D, Williams LaVonn	Nov/Dec 2011 Pg. 464-469
Infantile Hemangiomas, Part 1: Treatment with Oral Propranolol Hydrochloride Zur Eyal	Sep/Oct 2011 Pg. 358-366
Updated Case Report: The Use of Topical Concentrated Capsaicin Cream to Treat Erythromelalgia in a Pediatric Patient McElhiney Linda F	Sep/Oct 2011 Pg. 386-387
Folinic Acid, L-DOPA, and 5-hydroxytryptophan in Tetrahydrobiopterin Deficiency: Treatment Plan for a Pediatric Patient Bramwell Bethany	Jul/Aug 2011 Pg. 316-319
Case Report: The Use of Topical Concentrated Capsaicin Cream to Treat Erythromelalgia in a Pediatric Patient McElhiney Linda F	May/Jun 2011 Pg. 194-199
Extemporaneous Preparation of Sertraline Cream for Transdermal Administration Wynn Tom, Goetsch Daniel	May/Jun 2011 Pg. 200-203
Proton Pump Inhibitor Homogenous Suspensions: A Compounding Solution to Pediatric Gastroesophageal Reflux Disease Corsini Lindsay, Williams LaVonn A	Mar/Apr 2011 Pg. 124-128
Acetylcysteine 1% or 10% Oral Solution Allen Loyd V Jr	Mar/Apr 2011 Pg. 156
Glutathione 25% in Pluronic Lecithin Organogel Allen Loyd V Jr	Nov/Dec 2010 Pg. 518
Developing an Erythromycin Ophthalmic Ointment: Putting the Puzzle Pieces Together McElhiney Linda F	Jul/Aug 2010 Pg. 270-274
Calculating Carbohydrate Content of Compounded Medications for Patients on a Ketogenic Diet McElhiney Linda F, Cheng Angela, Meshberger Laura, Imai Lara	Jan/Feb 2010 Pg. 21-25
Diverse Challenges in Pediatric Compounding: Treating Pulmonary Hypertension, Uncombable Hair Syndrome, and Acanthamoeba keratitis Muller George, Young Thomas W, Reina Rachel, Caldwell Delmar R	Jan/Feb 2010 Pg. 40-45
When Traditional Medicine Fails Bash Robert	Jan/Feb 2010 Pg. 6-8
Calculations Stockton Shelly J	Jan/Feb 2010 Pg. 58-59
Emanuel Butt Paste Allen Loyd V Jr	Sep/Oct 2009 Pg. 431
Poster Presentation Report: Safety of Maternal Testosterone Therapy During Breast Feeding Glaser Rebecca L, Newman Mark, Parsons Melanie, Zava David, Glaser-Garbrick Daniel	Jul/Aug 2009 Pg. 314-317
Compounding Naltrexone for the Treatment of Autism Wynn Tom, Brunetti Sarah	Jul/Aug 2009 Pg. 296-299
Promethazine 25 mg/mL in Pluronic Lecithin Organogel for Nausea and Vomiting in a Pediatric Patient: A Case Report Muller George	May/Jun 2009 Pg. 220-221
Compounding for Pediatric Patients: Case Reports and Formulations Mixon William, Angelle Patricea, Yoch Douglas	Jan/Feb 2009 Pg. 6-12
Evaluation of Dosage Form Information Provided in Pediatric Drug Trial Reports Haase Mark R, Luedtke Sherry, Robles Janie, Parker Thomas, Leff Rich, Giacoia George	Jan/Feb 2009 Pg. 14-18
Calculations Stockton Shelly J	Jan/Feb 2009 Pg. 63
Acetaminophen, Pseudoephedrine Hydrochloride, and Chlorpheniramine Maleate Powder Packets Allen Loyd V Jr	Jan/Feb 2009 Pg. 64
Amphotericin B, Chloramphenicol Palmitate, Hydrocortisone, and Sulfanilamide Otic Powder Allen Loyd V Jr	Jan/Feb 2009 Pg. 65
Diaper Rash Cream with Miconazole Allen Loyd V Jr	Jan/Feb 2009 Pg. 68
Diphenhydramine Hydrochloride 25-mg Gelatin Troches Allen Loyd V Jr	Jan/Feb 2009 Pg. 69
Lack of Commercial Oral Drug Formulations for Children in Two Hospital Group Purchasing Agreements in France and Canada Prot-Labarthe Sonia, Bussieres Jean-Francois, Barett Pierre, Bourdon Olivier, Brion Francoise	Jul/Aug 2008 Pg. 365-367
Benzyl Benzoate Lotion Allen Loyd V Jr	May/Jun 2008 Pg. 261
Valsartan 4-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 2008 Pg. 269
Trimethoprim 10-mg/mL Oral Suspension Allen Loyd V Jr	Jan/Feb 2008 Pg. 73
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2 Giacoia George P, Taylor-Zapata Perdita, Mattison Donald	May/Jun 2007 Pg. 220-225
Methylphenidate 1-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 2007 Pg. 249
Challenges of Compounding for Patients on the Ketogenic Diet McElhiney Linda F	Mar/Apr 2007 Pg. 116-120
Ranitidine Hydrochloride 15-mg/mL Oral Liquid Allen Loyd V Jr	Mar/Apr 2007 Pg. 161
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development—Pediatric Formulations Initiative, Part 1 Giacoia George P, Taylor-Zapata Perdita, Mattison Donald	Jan/Feb 2007 Pg. 5-8
Principles of Pediatric Palliative Care and Pain Control Peralta Alexander Jr	Jan/Feb 2007 Pg. 10-15
Pediatric Oral Formulations: A Continual Challenge Hurtado Josephine, Moffett Brady S	Jan/Feb 2007 Pg. 17-19
Sevelamer Suspension in Children with End-Stage Renal Disease McElhiney Linda F	Jan/Feb 2007 Pg. 20-24
Case Report: Cocktail Dosing in a Premature Infant with a History of Cholestasis Fields Shannon W	Jan/Feb 2007 Pg. 26-27
Case Report: Treatment of Labial Adhesions in a Child Fields Shannon W	Jan/Feb 2007 Pg. 27
Calculations Stockton Shelly J	Jan/Feb 2007 Pg. 68
Caffeine Citrate 10-mg/mL Oral Liquid Allen Loyd V Jr	Jan/Feb 2007 Pg. 69
Carbidopa 1.25-mg/mL Oral Liquid Allen Loyd V Jr	Jan/Feb 2007 Pg. 70
Clonidine Hydrochloride 0.1-mg/mL Oral Liquid Allen Loyd V Jr	Jan/Feb 2007 Pg. 71
Methyldopa 25-mg/mL Oral Liquid Allen Loyd V Jr	Jan/Feb 2007 Pg. 75
Metolazone 1-mg/mL Oral Liquid Allen Loyd V Jr	Jan/Feb 2007 Pg. 76
Prednisone 10-mg/mL Oral Liquid Allen Loyd V Jr	Jan/Feb 2007 Pg. 77
Prednisolone Sodium Phosphate 10-mg/mL Oral Liquid Allen Loyd V Jr	Jan/Feb 2007 Pg. 78
Nitrazepam 1-mg/mL Oral Liquid Allen Loyd V Jr	Sep/Oct 2006 Pg. 388
Oral Rehydration Salts (World Health Organization/United Nations Children's Fund) Allen Loyd V Jr	Sep/Oct 2006 Pg. 390
Adderall 1-mg/mL Oral Liquid Allen Loyd V Jr	Jul/Aug 2006 Pg. 299
Lisinopril 1-mg/mL Oral Liquid Allen Loyd V Jr	Jul/Aug 2006 Pg. 302
Nifedipine 4-mg/mL Oral Liquid Allen Loyd V Jr	Jul/Aug 2006 Pg. 303
Propranolol Hydrochloride 1-mg/mL Oral Liquid Allen Loyd V Jr	Jul/Aug 2006 Pg. 304
Propylthiouracil 5-mg/mL Oral Liquid Allen Loyd V Jr	Jan/Feb 2006 Pg. 67
Prescription: Pediatric Formulation Initiatives Allen Loyd V Jr	Nov/Dec 2005 Pg. 410
Unlocking Autism: Is Compounding the Key? Vail Jane	Nov/Dec 2005 Pg. 413-420
Compounding for a Pediatric Hospital McElhiney Linda F	Nov/Dec 2005 Pg. 423-431
Wiping Out Diaper Rash Fields Shannon W	Nov/Dec 2005 Pg. 433-434 View Sample
Pediatric Oral Liquid Preparations Fonseca Simonne C, Ferreira Anderson de O	Nov/Dec 2005 Pg. 437-442
Basics of Compounding for Pediatric Patients: Commonly Prescribed Oral Liquid Formulations, Vehicles, and Stock Solutions Fonseca Simonne C	Nov/Dec 2005 Pg. 456-461
PostScription: Compounding Pharmacies and the Successful Treatment of Autism Neurander James A	Nov/Dec 2005 Pg. 487-488
Calculations Prince Shelly J	Jan/Feb 2005 Pg. 57
Stability of an Extemporaneously Compounded Propylthiouracil Suspension Alexander Kenneth S, Mitra Pallabi	Jan/Feb 2005 Pg. 82-86
A Need for Propylene Glycol-Free Ascorbic Acid Oral Liquid McElhiney Linda F	Nov/Dec 2004 Pg. 458-460
Domperidone in Lactation: Use as a Galactagogue Albright Lisa M	Sep/Oct 2004 Pg. 329-335
Head to Toe Solutions: A Quick Review of Current Therapies Paoletti James E	Sep/Oct 2004 Pg. 345-352
Book and Literature Reviews Reed-Kane Dana, Foy Elizabeth, MacCara Mary E	Jul/Aug 2004 Pg. 244-249
Gag Tablet Lollipops Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 184
Amiodarone HCl 5-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 2004 Pg. 214
Atenolol 2-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 2004 Pg. 215
Glycopyrrolate 0.5-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 2004 Pg. 218
Flucytosine 10-mg/mL Oral Liquid Allen Loyd V Jr	Mar/Apr 2004 Pg. 134
Griseofulvin 25-mg/mL Oral Liquid Allen Loyd V Jr	Mar/Apr 2004 Pg. 135
Stomatitis Mouthwash Allen Loyd V Jr	Mar/Apr 2004 Pg. 140
Tacrolimus 0.5-mg/mL Oral Liquid Allen Loyd V Jr	Mar/Apr 2004 Pg. 141
Tiagabine 1-mg/mL Oral Liquid Allen Loyd V Jr	Mar/Apr 2004 Pg. 142
Sulfasalazine 250-mg/5-mL Oral Liquid Allen Loyd V Jr	Nov/Dec 2003 Pg. 474
Stability of Two Concentrations of Tiagabine in an Extemporaneously Compounded Suspension Haase Mark R, Khan Mansoor A, Bonilla Jeremiah	Nov/Dec 2003 Pg. 485-489
Thioridazine HCl 100-mg/mL Concentrated Solution Allen Loyd V Jr	Sep/Oct 2003 Pg. 381
Isoniazid 10-mg/mL Oral Solution Allen Loyd V Jr	Sep/Oct 2003 Pg. 376
Ursodiol 150-mg Capsules Allen Loyd V Jr	Sep/Oct 2003 Pg. 382
Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride Alexander Kenneth S, Thyangarajapuram N	Sep/Oct 2003 Pg. 389-393
Educating the Caregiver and Community Pharmacist To Facilitate Provision of Consistent Compounded Medications from the Inpatient to Ambulatory Settings McElhiney Linda F	Sep/Oct 2003 Pg. 394-398
Stability of Hydralazine HCl in Both Flavored and Nonflavored Extemporaneous Preparations Okeke Claudia C, Medwick Thomas, Nairn Graham, Shaila Khuspe, Grady Lee T	Jul/Aug 2003 Pg. 313-319
Pediatric Dermatitis Remmert Renee	Nov/Dec 2002 Pg. 419-421
Excerpts from and Reviews of Current Published Literature: Pediatric Medications Foy Elizabeth, MacCara Mary E	Nov/Dec 2002 Pg. 423
Book Reviews: Compounding for Pediatric Patients Ashworth Lisa D, Reed-Kane Dana	Nov/Dec 2002 Pg. 424-425
Caffeine and Sodium Benzoate 250-mg/mL Injection Allen Loyd V Jr	Nov/Dec 2002 Pg. 449
Dimenhydrinate 50-mg/mL Injection Allen Loyd V Jr	Nov/Dec 2002 Pg. 451
Erythromycin 400-mg/mL and Rifampin 50-mg/mL Oral Liquid Allen Loyd V Jr	Sep/Oct 2002 Pg. 367
Topical Secretin for the Treatment of Autism King Erin, Toney Steve	Nov/Dec 2001 Pg. 436-437
Basics of Compounding: Suspensions Allen Loyd V Jr	Jul/Aug 2001 Pg. 294-297
Suspension Structured Vehicle, USP Allen Loyd V Jr	Jul/Aug 2001 Pg. 296
Sugar-Free Suspension Structured Vehicle, USP Allen Loyd V Jr	Jul/Aug 2001 Pg. 296
Spironolactone Oral Suspension 2-mg/mL Allen Loyd V Jr	Jul/Aug 2001 Pg. 297
Progesterone Oral Suspension 40-mg/mL Allen Loyd V Jr	Jul/Aug 2001 Pg. 297
Xanthan Gum Oral Suspension Vehicle 0.3% Allen Loyd V Jr	Jul/Aug 2001 Pg. 297
Pediatric Preoperative Cocktail Injection Allen Loyd V Jr	Jul/Aug 2001 Pg. 306
The Basics of Compounding Emulsions, Part 2 Allen Loyd V Jr	May/Jun 2001 Pg. 198-201
The Basics of Compounding Emulsions, Part 1 Allen Loyd V Jr	Mar/Apr 2001 Pg. 120-123
Pediatric Compounding: Coloring Outside the Lines Preckshot John	Jan/Feb 2001 Pg. 6-8
Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients Schotik Debora	Jan/Feb 2001 Pg. 9-12
Flavoring: Compounding a Treat Kloesel Lawson G	Jan/Feb 2001 Pg. 13-16
Autism in Children Cave Stephanie	Jan/Feb 2001 Pg. 18-19
Methylphenidate in the Treatment of Attention Deficit Disorders Tenreiro Kim	Jan/Feb 2001 Pg. 21-22
A Pediatric Miscellany: Excerpts from and Reviews of Current Published Literature Foy Elizabeth, MacCara Mary E	Jan/Feb 2001 Pg. 23-25
Compounding in History: Pediatric Considerations Worthen Dennis B	Jan/Feb 2001 Pg. 30-31
Electrolyte and Rehydration Powder for Solution-Example of Powder Formulations Allen Loyd V Jr	Jan/Feb 2001 Pg. 38
Cholestyramine 6.5% Ointment Allen Loyd V Jr	Jan/Feb 2001 Pg. 42
Ivermectin 0.8% Creme Rinse Allen Loyd V Jr	Jan/Feb 2001 Pg. 43
Lidocaine HCl 4%-Epinephrine HCl 0.05%-Tetracaine HCl 0.5% Topical Gel Allen Loyd V Jr	Jan/Feb 2001 Pg. 44
Lorazepam 1-mg Chewable Gummy Gels Allen Loyd V Jr	Jan/Feb 2001 Pg. 45
Metronidazole Benzoate 400-mg/5-mL Oral Suspension Allen Loyd V Jr	Jan/Feb 2001 Pg. 46
Natural Head Lice Repellant Spray Allen Loyd V Jr	Jan/Feb 2001 Pg. 48
Niacinamide 4% Acne Gel Allen Loyd V Jr	Jan/Feb 2001 Pg. 49
Promethazine HCl 50-mg/mL in PLO Gel Allen Loyd V Jr	Jan/Feb 2001 Pg. 51
Basics of Compounding: Compounding Suppositories: Part I - Theoretical Considerations Allen Loyd V Jr	Jul/Aug 2000 Pg. 289-293
Ondansetron HCl 8-mg/mL in PLO Allen Loyd V Jr	Jul/Aug 2000 Pg. 305
Compounding Ear, Nose and Throat Preparations Allen Loyd V Jr	May/Jun 2000 Pg. 164-169
Xylitol in the Prevention of Otitis Media Glasnapp Andrew	May/Jun 2000 Pg. 171-174
Sildenafil 0.2% Otic Drops Holland Robert T, Quisling Richard	May/Jun 2000 Pg. 175
Amphotericin B 100-mg Troches Allen Loyd V Jr	May/Jun 2000 Pg. 208
Nystatin 250,000-Unit and/or Tetracaine HCl 0.025% Popsicles Allen Loyd V Jr	May/Jun 2000 Pg. 214
Basics of Compounding: Compounding Solutions Allen Loyd V Jr	Mar/Apr 2000 Pg. 122-125
Sugar-Free Suspension Structured Vehicle, USP Allen Loyd V Jr	Mar/Apr 2000 Pg. 136
The Basics of Compounding: Compounding Hard, Soft and Chewable Troches/Lozenges/Drops Allen Loyd V Jr	Nov/Dec 1999 Pg. 461-465
Linguet Base (Soft Lozenge) Allen Loyd V Jr	Nov/Dec 1999 Pg. 462
Sorbitol Based Hard Lozenges Allen Loyd V Jr	Nov/Dec 1999 Pg. 462
Sucrose Based Hard Lozenges Allen Loyd V Jr	Nov/Dec 1999 Pg. 462
Polyethylene Glycol (PEG) Troches (Soft Lozenges) Allen Loyd V Jr	Nov/Dec 1999 Pg. 463
Polyethylene Glycol (PEG) Troches with Suspending Agent (Soft Lozenges) Allen Loyd V Jr	Nov/Dec 1999 Pg. 463
Chewable Lozenges Allen Loyd V Jr	Nov/Dec 1999 Pg. 464
Methotrexate 2.5-mg/5-mL Oral Liquid Allen Loyd V Jr	Nov/Dec 1999 Pg. 474
Extemporaneous Formulations in Pediatric Patients Nahata Milap C	Jul/Aug 1999 Pg. 274-276
Analysis of Extemporaneous Alprostadil Formulations Sarver Jeffrey G, Peng Ning, Lerdkanchanaporn Supaporn, Oravecz-Wilson Katherine, Alexander Kenneth S, Erhardt Paul W	Mar/Apr 1999 Pg. 148-155
Oral Ulceration Mouthwash Allen Loyd V Jr	Jan/Feb 1999 Pg. 10
Alternatives for the Lactose-Intolerant Patient Glasnapp Andrew	Nov/Dec 1998 Pg. 412
Pediatric Central Parenteral Nutrition Solution Allen Loyd V Jr	Sep/Oct 1998 Pg. 368
Pediatric Central Parenteral Nutrition Solution with Heparin Allen Loyd V Jr	Sep/Oct 1998 Pg. 369
Pediatric Peripheral Parenteral Nutrition Solution Allen Loyd V Jr	Sep/Oct 1998 Pg. 370
Malathion Topical Lotion: Therapy for Resistant Head Lice Glasnapp Andrew, Nguyen Linh	Jul/Aug 1998 Pg. 268-269
Compatibility and Stability of Ranitidine Hydrochloride with Six Cephalosporins During Simulated Y-Site Administration Inagaki Kazuhiro, Kambara Motoya, Mizuno Munemichi, Gill Mark A, Nishida Mikio	Jul/Aug 1998 Pg. 318-321
Tetracaine HCl 1%, Epinephrine HCl 0.025% and Cocaine HCl 4% Topical Solution and Gel Allen Loyd V Jr	Mar/Apr 1998 Pg. 159
Vehicles for Compounding Oral Liquids: Some Practical Considerations Palmer Henry A	Mar/Apr 1998 Pg. 160-161
Ondansetron Suppositories: Extemporaneous Preparation, Drug Release, Stability and Flux through Rabbit Rectal Membrane Tenjarla Srini N, Ward Earl S, Fox Janet L	Jan/Feb 1998 Pg. 83-88
Ketoconazole 20-mg/mL Oral Liquid Allen Loyd V Jr	Nov/Dec 1997 Pg. 414
Baclofen 10-mg/mL Oral Liquid Allen Loyd V Jr	Sep/Oct 1997 Pg. 321
Captopril 0.75-mg/mL Oral Liquid Allen Loyd V Jr	Sep/Oct 1997 Pg. 322
Diltiazem HCl 12-mg/mL Oral Suspension Allen Loyd V Jr	Sep/Oct 1997 Pg. 323
Stability of Bethanechol Chloride Oral Liquid Dosage Forms Gupta Vishnu D, Maswoswe J	Jul/Aug 1997 Pg. 278-279
Allopurinol 20-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 1997 Pg. 174
Dipyridamole 10-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 1997 Pg. 176
Labetalol HCl 40-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 1997 Pg. 179
Metoprolol Tartrate 10-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 1997 Pg. 180
Spironolactone 5-mg/mL with Hydrochlorothiazide 5-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 1997 Pg. 183
Spironolactone 25-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 1997 Pg. 184
Verapamil HCl 50-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 1997 Pg. 188
The Formulation Development and Stability of Spironolactone Suspension Alexander Kenneth S, Vangala Shyam Sundar KS, White Donald B, Dollimore David	May/Jun 1997 Pg. 195-199
The Formulation Development and Stability of Metronidazole Suspension Alexander Kenneth S, Vangala Shyam Sundar KS, Dollimore David	May/Jun 1997 Pg. 200-205
Metronidazole 15-mg/mL Suspension Gupta Vishnu D, Maswoswe J, Bailey RE	May/Jun 1997 Pg. 202
Compounding for the Pediatric Patient Allen Loyd V Jr	Mar/Apr 1997 Pg. 84-86
Attention Deficit Hyperactivity Disorder Allen Loyd V Jr	Mar/Apr 1997 Pg. 87-89
Flavors and Flavoring Allen Loyd V Jr	Mar/Apr 1997 Pg. 90-92
Compounded Suppositories and Pharmaceutical Care Duncan-Hewitt Wendy, Rains John	Mar/Apr 1997 Pg. 93-99
Acetazolamide 25-mg/mL Oral Liquid Allen Loyd V Jr	Mar/Apr 1997 Pg. 101
Azathioprine 50-mg/mL Oral Liquid Allen Loyd V Jr	Mar/Apr 1997 Pg. 102
Flecainide Acetate 20-mg/mL Oral Liquid Allen Loyd V Jr	Mar/Apr 1997 Pg. 103
Methylcellulose 1% to 5% Solutions Allen Loyd V Jr	Mar/Apr 1997 Pg. 104
Methylcellulose Oral-Liquid Vehicles Allen Loyd V Jr	Mar/Apr 1997 Pg. 105
Pediatric Chewable Gummy Gel Base Allen Loyd V Jr	Mar/Apr 1997 Pg. 106
Pediatric Chocolate Troche Base Allen Loyd V Jr	Mar/Apr 1997 Pg. 106
Pediatric Chewable Gummy Gels Allen Loyd V Jr	Mar/Apr 1997 Pg. 107
Pediatric Chocolate Troche Allen Loyd V Jr	Mar/Apr 1997 Pg. 108
Nystatin Popsicles Allen Loyd V Jr	Mar/Apr 1997 Pg. 109
Procainamide HCl 50-mg/mL Oral Liquid Allen Loyd V Jr	Mar/Apr 1997 Pg. 110
Syrup NF Allen Loyd V Jr	Mar/Apr 1997 Pg. 111
Tetracaine 20-mg Lollipops Allen Loyd V Jr	Mar/Apr 1997 Pg. 112
Tetracycline Compound Troche Allen Loyd V Jr	Mar/Apr 1997 Pg. 113
Xanthan Gum Suspension Vehicle (0.2% to 0.5%) Allen Loyd V Jr	Mar/Apr 1997 Pg. 114
Omeprazole (Prilosec) in the Atypical Patient, Administration of Kane Dana Lynn	Jan/Feb 1997 Pg. 13
HDDM Hard Troche Allen Loyd V Jr	Jan/Feb 1997 Pg. 29
HDDM Soft Troche Allen Loyd V Jr	Jan/Feb 1997 Pg. 30
HDDM Sugar Troche Allen Loyd V Jr	Jan/Feb 1997 Pg. 30
Metoclophen Nausea Suppositories Allen Loyd V Jr	Jan/Feb 1997 Pg. 31
Metoclophen-Modified Nausea Suppositories Allen Loyd V Jr	Jan/Feb 1997 Pg. 31
Stability of an Extemporaneously Formulated Levothyroxine Sodium Syrup Compounded from Commercial Tablets Alexander Kenneth S, Kothapalli Madhu R, Dollimor David	Jan/Feb 1997 Pg. 60-63
Return to Top

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
GERIATRICS RELATED ARTICLES
Compounding for the Treatment of COVID-19 and Long COVID, Part 3: The Role of Toll-like Receptors in SARS-CoV-2 Infection and COVID Development Riepl Mike, Kaiser Joe	May/Jun 2023 Pg. 192-200
Glycopyrrolate Sorbitol Lollipops for Drooling: Two Case Reports Agbi Kelechi E, Carvalho Maria, Vieira-Banov Fabiana	Nov/Dec 2021 Pg. 464-467
Compatibility of Gestrinone, Nimesulide, and Piroxicam in Pentravan for Transdermal and Transmucosal Application Polonini Hudson, de Oliveira Ferreira Anderson, Dijkers Eli	Sep/Oct 2021 Pg. 422-426
Always the Right Dose? Content Uniformity in Over 100 Different Formulations Tested Dijkers Eli, Polonini Hudson, de Oliveira Ferreira Anderson	Sep/Oct 2020 Pg. 408-412
Suspensions as a Valuable Alternative to Extemporaneously Compounded Capsules Dijkers Eli, Nanhekhan Valerie, Thorissen Astrid, Polonini Hudson	Mar/Apr 2017 Pg. 171-175
Efficacy and Clinical Value of Commonly Compounded Hormone Replacement Therapy: A Literature Review Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi	Jan/Feb 2015 Pg. 6-12
Treatment Options for Male Hypogonadism Biundo Bruce	Jan/Feb 2013 Pg. 28-38
Testosterone Levels in an Aging Population: Screen, Measure, and Restore Kells John, DollbaumCharles M	Mar/Apr 2011 Pg. 102-112
Clozapine 20-mg/mL Oral Suspension Allen Loyd V Jr	May/Jun 2010 Pg. 243
PreScription: The Ages of Man Allen Loyd V Jr	Mar/Apr 2010 Pg. 92
Emerging Evidence for Androgen Replacement Therapy in Aging Men Bramwell Bethany L	Mar/Apr 2010 Pg. 94-99
PreScription: Geriatric Compounding: An Opportunity for Pharmacists Allen Loyd V Jr	Nov/Dec 2009 Pg. 492
Low Testosterone in Older Men: A Discussion and Review of Literature on Health Consequences of Hypogonadism in the Aging Male Biundo Bruce	Nov/Dec 2009 Pg. 494-496
Compliance to Treatment in Elderly Dysphagic Patients: Potential Benefits of Alternate Dosage Forms Bramwell Bethany L	Nov/Dec 2009 Pg. 498-505
Marketing the Geriatric Patient Moore Renee	Nov/Dec 2009 Pg. 538-539
Calculations Stockton Shelly J	Nov/Dec 2009 Pg. 545
Selegiline Hydrochloride 1-mg/0.05-mL Oral Suspension in Oil Allen Loyd V Jr	Jul/Aug 2009 Pg. 340
Arthritis Epidemiology Impacts Pharmacists Vance Dwight A	Nov/Dec 2008 Pg. 476-480
Intravitreal Bevacizumab for Choroidal Neovascularization in Age-Related Macular Degeneration Dib Jean G, Abdulmohsin Saud	Jan/Feb 2008 Pg. 8-14
Calculations Stockton Shelly J	Jan/Feb 2007 Pg. 68
Carbidopa 1.25-mg/mL Oral Liquid Allen Loyd V Jr	Jan/Feb 2007 Pg. 70
Clonidine Hydrochloride 0.1-mg/mL Oral Liquid Allen Loyd V Jr	Jan/Feb 2007 Pg. 71
Methyldopa 25-mg/mL Oral Liquid Allen Loyd V Jr	Jan/Feb 2007 Pg. 75
Metolazone 1-mg/mL Oral Liquid Allen Loyd V Jr	Jan/Feb 2007 Pg. 76
Propranolol Hydrochloride 1-mg/mL Oral Liquid Allen Loyd V Jr	Jul/Aug 2006 Pg. 304
Stability of an Extemporaneously Compounded Propylthiouracil Suspension Alexander Kenneth S, Mitra Pallabi	Jan/Feb 2005 Pg. 82-86
Book and Literature Reviews Reed-Kane Dana, Foy Elizabeth, MacCara Mary E	Jul/Aug 2004 Pg. 244-249
Case Report: Wound Care of a Diabetic Foot Ulcer Wynn Tom	Jul/Aug 2004 Pg. 265-267
Current Topical Treatments in Wound Healing - Part 1 Helmke Christopher D	Jul/Aug 2004 Pg. 269-274
Atropine 1-mg Gelatin Troches Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 184
Clonidine HCl 0.2%/Gabapentin 6%/Ketamine HCl 10% in Pluronic Lecithin Organogel (PLO) Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 185
Pain Management in the Elderly Peralta Alexander Jr	May/Jun 2004 Pg. 187-191
Amiodarone HCl 5-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 2004 Pg. 214
Atenolol 2-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 2004 Pg. 215
Glycopyrrolate 0.5-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 2004 Pg. 218
Flucytosine 10-mg/mL Oral Liquid Allen Loyd V Jr	Mar/Apr 2004 Pg. 134
Griseofulvin 25-mg/mL Oral Liquid Allen Loyd V Jr	Mar/Apr 2004 Pg. 135
Stomatitis Mouthwash Allen Loyd V Jr	Mar/Apr 2004 Pg. 140
Tacrolimus 0.5-mg/mL Oral Liquid Allen Loyd V Jr	Mar/Apr 2004 Pg. 141
Tiagabine 1-mg/mL Oral Liquid Allen Loyd V Jr	Mar/Apr 2004 Pg. 142
Extemporaneous Formulation and Stability Testing of Mexiletine HCl Solution Alexander Kenneth S, Kaushik Sarita	Mar/Apr 2004 Pg. 147-152
Ergoloid Mesylate 1-mg/mL Oral Liquid Allen Loyd V Jr	Nov/Dec 2003 Pg. 470
Perphenazine 2.5-mg/5-mL Syrup Allen Loyd V Jr	Nov/Dec 2003 Pg. 473
Sulfasalazine 250-mg/5-mL Oral Liquid Allen Loyd V Jr	Nov/Dec 2003 Pg. 474
Thioridazine HCl 100-mg/mL Concentrated Solution Allen Loyd V Jr	Sep/Oct 2003 Pg. 381
Isoniazid 10-mg/mL Oral Solution Allen Loyd V Jr	Sep/Oct 2003 Pg. 376
Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride Alexander Kenneth S, Thyangarajapuram N	Sep/Oct 2003 Pg. 389-393
Educating the Caregiver and Community Pharmacist To Facilitate Provision of Consistent Compounded Medications from the Inpatient to Ambulatory Settings McElhiney Linda F	Sep/Oct 2003 Pg. 394-398
Stability of Hydralazine HCl in Both Flavored and Nonflavored Extemporaneous Preparations Okeke Claudia C, Medwick Thomas, Nairn Graham, Shaila Khuspe, Grady Lee T	Jul/Aug 2003 Pg. 313-319
Levofloxacin 250-mg/5mL Oral Liquid Allen Loyd V Jr	Jan/Feb 2003 Pg. 60
Ofloxacin 250-mg/5-mL Oral Liquid Allen Loyd V Jr	Jan/Feb 2003 Pg. 60
Erythromycin 400-mg/mL and Rifampin 50-mg/mL Oral Liquid Allen Loyd V Jr	Sep/Oct 2002 Pg. 367
Mild Laxative Worthen Dennis B	May/Jun 2002 Pg. 185
Liver Pills for All Obstructions of the Liver, Gall Ducts, and Bowel Worthen Dennis B	May/Jun 2002 Pg. 185
Compounding for Geriatrics Patients Armstrong Eldon	May/Jun 2002 Pg. 168-170
Estrogen Replacement Therapy in the Treatment of Alzheimer's Disease Osburn Jennifer	May/Jun 2002 Pg. 171-176
Book Reviews: Wellness, Nutrition and Geriatrics Reed-Kane Dana, Ashworth Lisa D	May/Jun 2002 Pg. 180-181
Carbidopa 2-mg/mL and Levodopa 250-mg/mL Oral Suspension Allen Loyd V Jr	May/Jun 2002 Pg. 202
Bioidentical Hormones in the Treatment of Osteoporosis Boomsma Diane	Sep/Oct 2001 Pg. 339-341
Basics of Compounding: Suspensions Allen Loyd V Jr	Jul/Aug 2001 Pg. 294-297
Suspension Structured Vehicle, USP Allen Loyd V Jr	Jul/Aug 2001 Pg. 296
Sugar-Free Suspension Structured Vehicle, USP Allen Loyd V Jr	Jul/Aug 2001 Pg. 296
Spironolactone Oral Suspension 2-mg/mL Allen Loyd V Jr	Jul/Aug 2001 Pg. 297
Progesterone Oral Suspension 40-mg/mL Allen Loyd V Jr	Jul/Aug 2001 Pg. 297
Xanthan Gum Oral Suspension Vehicle 0.3% Allen Loyd V Jr	Jul/Aug 2001 Pg. 297
The Basics of Compounding Emulsions, Part 2 Allen Loyd V Jr	May/Jun 2001 Pg. 198-201
The Basics of Compounding Emulsions, Part 1 Allen Loyd V Jr	Mar/Apr 2001 Pg. 120-123
Electrolyte and Rehydration Powder for Solution-Example of Powder Formulations Allen Loyd V Jr	Jan/Feb 2001 Pg. 38
Milk of Magnesia Concentrate, Unflavored Allen Loyd V Jr	Jan/Feb 2001 Pg. 47
Nicotinamide-Adenine Dinucleotide (NADH) in Parkinson's Disease and Alzheimer's Disease Glasnapp Andrew, Schaefer Erin	Jul/Aug 2000 Pg. 276-279
Amphotericin B 100-mg Troches Allen Loyd V Jr	May/Jun 2000 Pg. 208
Saliva Substitute for Dry Mouth/Throat Allen Loyd V Jr	May/Jun 2000 Pg. 215
Basics of Compounding: Compounding Solutions Allen Loyd V Jr	Mar/Apr 2000 Pg. 122-125
Osteoarthritis: Other Options Berrettini Lee	Nov/Dec 1999 Pg. 433-435
Methotrexate 2.5-mg/5-mL Oral Liquid Allen Loyd V Jr	Nov/Dec 1999 Pg. 474
Alternatives for the Lactose-Intolerant Patient Glasnapp Andrew	Nov/Dec 1998 Pg. 412
Treatment of Skin Aging with Topical Estrogens Schmidt Jolanta B, Binder Martina, Demschik Gabriele, Bieglmayer Christian, Reiner Angelika	Jul/Aug 1998 Pg. 270-275
Stability of Ciprofloxacin in Extemporaneous Oral Liquid Dosage Form Johnson Cary E, Wong Douglas V, Hoppe Heather L, Bhatt-Mehta Varsha	Jul/Aug 1998 Pg. 314-317
Vehicles for Compounding Oral Liquids: Some Practical Considerations Palmer Henry A	Mar/Apr 1998 Pg. 160-161
Estrogen in the Treatment and Prevention of Alzheimer's Disease Paganini-Hill Annlia, Henderson Victor W	Jan/Feb 1998 Pg. 24-29
Ketoconazole 20-mg/mL Oral Liquid Allen Loyd V Jr	Nov/Dec 1997 Pg. 414
Baclofen 10-mg/mL Oral Liquid Allen Loyd V Jr	Sep/Oct 1997 Pg. 321
Captopril 0.75-mg/mL Oral Liquid Allen Loyd V Jr	Sep/Oct 1997 Pg. 322
Diltiazem HCl 12-mg/mL Oral Suspension Allen Loyd V Jr	Sep/Oct 1997 Pg. 323
Metolazone 1-mg/mL Oral Suspension Allen Loyd V Jr	Sep/Oct 1997 Pg. 329
Stability of Bethanechol Chloride Oral Liquid Dosage Forms Gupta Vishnu D, Maswoswe J	Jul/Aug 1997 Pg. 278-279
Creative Compounding for the Geriatric Patient Allen Loyd V Jr	May/Jun 1997 Pg. 147-148
Drug Products and Drug Packaging for the Elderly Allen Loyd V Jr	May/Jun 1997 Pg. 150-151
Common Diseases of the Elderly Allen Loyd V Jr	May/Jun 1997 Pg. 152
Allopurinol 20-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 1997 Pg. 174
Dipyridamole 10-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 1997 Pg. 176
Labetalol HCl 40-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 1997 Pg. 179
Metoprolol Tartrate 10-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 1997 Pg. 180
Spironolactone 5-mg/mL with Hydrochlorothiazide 5-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 1997 Pg. 183
Spironolactone 25-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 1997 Pg. 184
Verapamil HCl 50-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 1997 Pg. 188
Metronidazole 15-mg/mL Suspension Gupta Vishnu D, Maswoswe J, Bailey RE	May/Jun 1997 Pg. 202
Acetazolamide 25-mg/mL Oral Liquid Allen Loyd V Jr	Mar/Apr 1997 Pg. 101
Azathioprine 50-mg/mL Oral Liquid Allen Loyd V Jr	Mar/Apr 1997 Pg. 102
Flecainide Acetate 20-mg/mL Oral Liquid Allen Loyd V Jr	Mar/Apr 1997 Pg. 103
Methylcellulose 1% to 5% Solutions Allen Loyd V Jr	Mar/Apr 1997 Pg. 104
Methylcellulose Oral-Liquid Vehicles Allen Loyd V Jr	Mar/Apr 1997 Pg. 105
Procainamide HCl 50-mg/mL Oral Liquid Allen Loyd V Jr	Mar/Apr 1997 Pg. 110
Syrup NF Allen Loyd V Jr	Mar/Apr 1997 Pg. 111
Tetracaine 20-mg Lollipops Allen Loyd V Jr	Mar/Apr 1997 Pg. 112
Tetracycline Compound Troche Allen Loyd V Jr	Mar/Apr 1997 Pg. 113
Xanthan Gum Suspension Vehicle (0.2% to 0.5%) Allen Loyd V Jr	Mar/Apr 1997 Pg. 114
Stability of Allopurinol Suspension Compounded from Tablets Alexander Kenneth S, Davar Nipun, Parker Gordon A	Mar/Apr 1997 Pg. 128-131
Hospice Care and the Pharmacist Allen Loyd V Jr	Jan/Feb 1997 Pg. 10-12
Omeprazole (Prilosec) in the Atypical Patient, Administration of Kane Dana Lynn	Jan/Feb 1997 Pg. 13
Stability of an Extemporaneously Formulated Levothyroxine Sodium Syrup Compounded from Commercial Tablets Alexander Kenneth S, Kothapalli Madhu R, Dollimor David	Jan/Feb 1997 Pg. 60-63
Return to Top

	Instant Online Access